TransCode Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAZ and other ETFs, options, and stocks.About RNAZ
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
RNAZ Key Statistics
Stock Snapshot
The current TransCode Therapeutics(RNAZ) stock price is $6.00, with a market capitalization of 5.7M. The stock trades at a price-to-earnings (P/E) ratio of -0.13.
As of 2026-05-21, TransCode Therapeutics(RNAZ) stock has fluctuated between $6.00 and $6.14. The current price stands at $6.00, placing the stock 0.0% above today's low and -2.2% off the high.
TransCode Therapeutics(RNAZ) shares are trading with a volume of 1.61K, against a daily average of 11.09K.
During the past year, TransCode Therapeutics(RNAZ) stock moved between $5.56 at its lowest and $20.99 at its peak.
During the past year, TransCode Therapeutics(RNAZ) stock moved between $5.56 at its lowest and $20.99 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.